The diffuse cutaneous systemic sclerosis market landscape is evolving from conventional symptom-focused strategies toward therapies that specifically target fibrosis and immune modulation, addressing ...

Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international trial which could revolutionise care for people living with a rare and ...

Vidofludimus calcium reduced the risk of confirmed disability worsening in people with progressive and relapsing forms of MS, ...

Allogene Therapeutics, Inc. ( NASDAQ: ALLO) Citi's SMID Call Series 2025 October 2, 2025 1:00 PM EDT ...